NYSEMKT: OGEN
Oragenics Inc Stock Ownership - Who owns Oragenics?

Insider buying vs selling

Have Oragenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Odyssey Health Inc10% Owner2025-06-185,044$4.26
$21.49kSell
Odyssey Health Inc10% Owner2025-06-172,000$4.46
$8.92kSell
Odyssey Health Inc10% Owner2025-06-165,000$4.45
$22.25kSell
Odyssey Health Inc10% Owner2025-06-135,000$4.27
$21.35kSell
Alan W. DuntonDirector2024-12-0666$0.36
$23.76Sell
Fred TellingDirector2024-12-063,597$0.36
$1.29kSell

1 of 1

OGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OGEN insiders and whales buy or sell their stock.

OGEN Shareholders

What type of owners hold Oragenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk2,776.34%19,874,069$26.23MInsider
Koski Family LP1,373.72%9,833,595$12.98MInsider
Jeffrey D. Hillman458.27%3,280,434$4.33MInsider
Christine L. Koski293.36%2,100,000$2.77MInsider
David Brian Hirsch139.70%1,000,000$1.32MInsider
Robert T. Zahradnik123.07%881,000$1.16MInsider
George T. Hawes104.13%745,397$983.92kInsider
Mento Soponis72.66%520,133$686.58kInsider
John N. Bonfiglio53.82%385,255$508.54kInsider
Bruce A. Cassidy Sr.49.55%354,728$468.24kInsider

1 of 3

OGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OGEN0.26%99.74%Net Selling
ADTX0.78%99.22%
AEON4.44%95.56%Net Buying
CDT0.03%99.97%Net BuyingNet Buying
REVB1.02%98.98%Net Buying

Oragenics Stock Ownership FAQ

Who owns Oragenics?

Oragenics (NYSEMKT: OGEN) is owned by 14.71% institutional shareholders, 5,538.63% Oragenics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Oragenics shareholder, owning 19.87M shares representing 2,776.34% of the company. Randal J. Kirk's Oragenics shares are currently valued at $26.23M.

If you're new to stock investing, here's how to buy Oragenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.